These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 1321865)

  • 1. Herpes simplex virus infection during foscarnet therapy.
    Cotte L; Langlois M; Trepo C
    J Infect Dis; 1992 Aug; 166(2):447-8. PubMed ID: 1321865
    [No Abstract]   [Full Text] [Related]  

  • 2. Foscarnet approved for cytomegalovirus retinitis.
    Am Fam Physician; 1991 Nov; 44(5):1890. PubMed ID: 1659165
    [No Abstract]   [Full Text] [Related]  

  • 3. Foscarnet for CMV retinitis.
    Wood CA
    Lancet; 1992 Feb; 339(8791):501. PubMed ID: 1346861
    [No Abstract]   [Full Text] [Related]  

  • 4. Foscarnet.
    Med Lett Drugs Ther; 1992 Jan; 34(861):3-4. PubMed ID: 1309469
    [No Abstract]   [Full Text] [Related]  

  • 5. Didanosine and foscarnet marketed for use by patients with AIDS.
    Clin Pharm; 1992 Jan; 11(1):4, 6. PubMed ID: 1309689
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of cytomegalovirus retinitis with trisodium phosphonoformate hexahydrate (Foscarnet).
    Walmsley SL; Chew E; Read SE; Vellend H; Salit I; Rachlis A; Fanning MM
    J Infect Dis; 1988 Mar; 157(3):569-72. PubMed ID: 2830347
    [No Abstract]   [Full Text] [Related]  

  • 7. Seeing the way forward for treatment of CMV retinitis.
    Lancet; 1991 Dec; 338(8781):1494-5. PubMed ID: 1683924
    [No Abstract]   [Full Text] [Related]  

  • 8. Cytomegalovirus and AIDS.
    Evans JK; Scoular A; Miller RF
    Genitourin Med; 1992 Feb; 68(1):60-1. PubMed ID: 1312508
    [No Abstract]   [Full Text] [Related]  

  • 9. Foscarnet for cytomegalovirus retinitis.
    Singer DR; Fallon TJ; Schulenburg WE; Williams G; Cohen J
    Ann Intern Med; 1985 Dec; 103(6 ( Pt 1)):962. PubMed ID: 2998255
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical implications of herpesvirus infections in patients with AIDS. Introduction.
    Masur H
    Am J Med; 1992 Feb; 92(2A):1S-2S. PubMed ID: 1310568
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of CMV retinitis.
    Bachman DM
    N Engl J Med; 1992 Jun; 326(25):1702; author reply 1702-3. PubMed ID: 1317012
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of CMV retinitis.
    Skolnik PR
    N Engl J Med; 1992 Jun; 326(25):1701; author reply 1702-3. PubMed ID: 1317010
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of CMV retinitis.
    Deray G; Katlama C; Jacobs C
    N Engl J Med; 1992 Jun; 326(25):1702. PubMed ID: 1317011
    [No Abstract]   [Full Text] [Related]  

  • 14. Foscarnet therapy for ganciclovir-resistant cytomegalovirus retinitis in patients with AIDS.
    Jacobson MA; Drew WL; Feinberg J; O'Donnell JJ; Whitmore PV; Miner RD; Parenti D
    J Infect Dis; 1991 Jun; 163(6):1348-51. PubMed ID: 1645385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of CMV retinitis.
    Morris DJ
    Lancet; 1992 Jan; 339(8787):247. PubMed ID: 1346202
    [No Abstract]   [Full Text] [Related]  

  • 16. The treatment of cytomegalovirus in AIDS--more than meets the eye.
    Hirsch MS
    N Engl J Med; 1992 Jan; 326(4):264-6. PubMed ID: 1309391
    [No Abstract]   [Full Text] [Related]  

  • 17. Simultaneous treatment of cytomegalovirus retinitis with ganciclovir and foscarnet.
    Nelson MR; Barter G; Hawkins D; Gazzard BG
    Lancet; 1991 Jul; 338(8761):250. PubMed ID: 1676798
    [No Abstract]   [Full Text] [Related]  

  • 18. Nephrogenic diabetes insipidus associated with foscarnet treatment of cytomegalovirus retinitis.
    Farese RV; Schambelan M; Hollander H; Stringari S; Jacobson MA
    Ann Intern Med; 1990 Jun; 112(12):955-6. PubMed ID: 2160217
    [No Abstract]   [Full Text] [Related]  

  • 19. AIDS file.
    Am J Nurs; 1991 Oct; 91(10):17. PubMed ID: 1654745
    [No Abstract]   [Full Text] [Related]  

  • 20. Successful foscarnet therapy for cytomegalovirus retinitis in an AIDS patient undergoing hemodialysis: rationale for empiric dosing and plasma level monitoring.
    MacGregor RR; Graziani AL; Weiss R; Grunwald JE; Gambertoglio JG
    J Infect Dis; 1991 Oct; 164(4):785-7. PubMed ID: 1654363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.